Skip to main content
Equibles
VCYT logo

VCYT · Veracyte, Inc. · Analyst Estimates

Track VCYT — free

Use VCYT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VCYT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$50.28 +2.08 (+4.32%) Q2 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.12B
Shares
80.39M
Volume · Oct 27 1.81M Avg daily vol (3M) 1.38M

Analyst Estimates

Compare analyst forecasts for Veracyte, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-24 13:14 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.78
1.91
1.99
11
1.91
1.91
1.91
1.80
1
1
0
1
Revenue
USD
Publication date not stated
589.00M
593.65M
597.90M
12
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.67
1.94
2.11
11
1.95
1.95
1.95
1.89
2
2
0
1
Revenue
USD
Publication date not stated
649.00M
659.70M
681.00M
12
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.35
0.41
0.45
11
0.41
0.41
0.41
0.44
1
1
0
0
Revenue
USD
Publication date not stated
144.90M
147.10M
148.60M
12
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.36
0.45
0.50
11
0.45
0.45
0.45
0.45
2
3
0
0
Revenue
USD
Publication date not stated
154.70M
157.20M
159.90M
11
 — — — — — — — —
Key facts CIK 1384101 CUSIP 92337F107 13F (30d) 57 filings 57 filers Visit website Investor relations